Core Viewpoint - The competition for exclusive agency rights between Ruoyuchen and Shuiyang Co. regarding the Spanish medical beauty brand Mestique's oral beauty product line in China has emerged, with both companies claiming to hold exclusive rights [1][2][3]. Summary by Sections Agency Rights Dispute - Ruoyuchen claims to be the exclusive general agent for Mestique's core oral beauty product line in China, responsible for brand promotion and sales [2][3]. - Shuiyang Co. asserts that it has a valid exclusive distribution agreement with Mestique, managing all official online channels in China [2][3]. Financial Performance and Market Position - Ruoyuchen's financial performance has shown volatility since its IPO, with 2021 revenue at 1.288 billion yuan, a 13.44% increase, but a net profit decline of 67.02% [4]. - In contrast, Ruoyuchen's revenue growth has improved significantly in 2023, with increases of 12.25%, 29.26%, and 85.3% in the first three quarters of 2023, 2024, and 2025 respectively [5]. Strategic Importance of Mestique - Both companies recognize the importance of securing the agency rights for Mestique's products, which have a market size in the millions, to enhance their growth prospects [1][4]. - Mestique's oral beauty products, particularly the Brightening Drink, have gained significant market traction, with Shuiyang Co. reporting a 50% increase in GMV due to effective marketing strategies [6]. Industry Trends - The beauty industry is witnessing a shift towards self-owned brands among beauty operators, with Ruoyuchen focusing on enhancing its brand management capabilities and expanding its product portfolio [5][6]. - Experts suggest that developing strong self-owned brands may be a more sustainable growth path for beauty operators, as seen in Ruoyuchen's recent performance [6].

Core Viewpoint - The competition for exclusive agency rights in the oral beauty product market between Ruoyuchen and Shuiyang Co. is intensifying, with both companies claiming to be the exclusive agent for the Spanish brand Mestique in China [1][3][4]. Summary by Sections Agency Rights Dispute - Ruoyuchen claims to be the exclusive agent for Mestique's core oral beauty product line in China, responsible for brand promotion and sales [3][4]. - Shuiyang Co. asserts that it holds the exclusive distribution agreement with Mestique, managing all official online channels in China [3][4]. - The dispute highlights the importance of exclusive agency rights in a market with a significant scale, estimated in the millions [1][3]. Market Potential - The oral beauty product market is experiencing rapid growth, with user numbers exceeding 65 million in 2023, a 28% increase year-on-year [7]. - The demographic of 18-35-year-old women constitutes 72% of the consumer base, indicating a strong market potential [7]. Company Performance - Ruoyuchen has been undergoing a transformation, shifting from brand operation to brand management, which has shown positive results in recent years [5][6]. - Financial data shows Ruoyuchen's revenue growth from 2023 to 2025, with increases of 12.25%, 29.26%, and 85.3% respectively, alongside significant net profit growth [5][6]. Competitive Landscape - The oral beauty market is becoming increasingly competitive, with new entrants like Shiseido and Amorepacific launching their own brands and products [8]. - The presence of various players in the market poses challenges for both Ruoyuchen and Shuiyang Co. in maintaining their market positions [8]. Strategic Directions - Industry experts suggest that developing strong proprietary brands may be a beneficial direction for beauty operators, as seen in Ruoyuchen's recent performance [9].

Investment Rating - The report maintains a "Recommended" rating for the company [4] Core Insights - The company achieved a revenue of 2.5 billion yuan in H1 2025, representing a year-on-year increase of 9.02%, and a net profit of 123 million yuan, up 16.54% year-on-year [1] - The self-owned brand revenue accounted for over 40% of total revenue, with significant contributions from mask products and lotion/cream products [1][2] - The gross margin improved by 3.13 percentage points year-on-year to 64.61% in H1 2025, with self-owned brand gross margin reaching 76.83% [2] - The company is focusing on high-end brand development, with several brands contributing to long-term growth potential [3] Financial Performance Summary - For H1 2025, the company reported a net profit margin of 4.93%, an increase of 0.32 percentage points year-on-year [2] - The projected net profits for 2025, 2026, and 2027 are 253 million yuan, 335 million yuan, and 429 million yuan, respectively, with growth rates of 129.6%, 32.7%, and 28.0% [4][5] - The company’s PE ratios for the next three years are projected to be 33X, 25X, and 20X [4][5]

Core Insights - The company reported a revenue of 2.5 billion yuan for 1H25, representing a year-on-year increase of 9.0%, with a net profit attributable to shareholders of 123 million yuan, up 16.5% [1] - In Q2 2025, the revenue reached 1.414 billion yuan, reflecting a growth of 12.2%, and the net profit attributable to shareholders was 81 million yuan, an increase of 23.8% [1] Revenue Breakdown - The revenue from facial masks in 1H25 was 423 million yuan, growing by 18.0%, with a gross margin of 73.0%, up 5.1 percentage points [1] - The revenue from lotions and creams was 1.997 billion yuan, an increase of 11.7%, with a gross margin of 62.0%, up 3.5 percentage points [1] - Revenue from the Taobao channel was 595 million yuan, up 3.6%, while revenue from Douyin reached 998 million yuan, growing by 16.1% [1] Profitability and Costs - The overall gross margin for 1H25 was 64.6%, an increase of 3.1 percentage points, and the net profit margin was 4.9%, up 0.3 percentage points [1] - The expense ratios for sales, management, and R&D were 48.9%, 5.2%, and 1.8%, respectively, with year-on-year increases of 2.1 percentage points, 0.5 percentage points, and 0.4 percentage points [1] Product and Channel Development - The company has successfully completed the high-end and global transformation of its proprietary brand system, with significant growth in key products such as the EDB super mask and collagen essence water [1] - EDB's online sales through self-broadcasting and flat sales are increasing, while offline, the company has opened 8 direct stores in high-end malls in Shanghai [2] - The company has established a CP system covering skincare, makeup, personal care, perfume, and health food, with notable sales achievements in various product lines [2] Future Outlook - The company is expected to stabilize its operations in 2025 and continue building its high-end brand matrix, with projected net profits of 252 million yuan, 319 million yuan, and 386 million yuan for 2025-2027 [2]

Core Insights - The company Meistick has been recognized as the "Top 1 in online sales of high-end oral skin color management" by iiMedia Research, a leading third-party data mining and analysis agency in the new economy sector [1][5][10] Industry Overview - The medical beauty and skincare industry is experiencing rapid growth driven by the dual forces of beauty economy and heightened health awareness, with the Chinese skincare market projected to reach 301.4 billion yuan in 2024, reflecting a year-on-year growth of 7.5% [3][5] - The increasing consumer awareness of skincare has shifted the focus from basic cleansing and moisturizing to more precise and effective skincare solutions [3][5] Consumer Trends - The "ingredient-focused" consumer group is expanding, showing unprecedented attention to product ingredients, efficacy, and safety, leading to a demand for more precise, efficient, and safe skincare experiences [5][11] - Key consumer demands include anti-wrinkle and anti-aging (55.1%), skin whitening and spot removal (51.0%), and moisturizing (47.6%), driving the industry towards precision and professionalism [7][11] Company Positioning - Meistick, with a 40-year history, is a Spanish professional skincare brand that emphasizes scientific innovation and has established a significant presence in the global high-end skincare market [7][10] - The company has achieved over tenfold growth in its all-channel GMV, from 50 million yuan in 2021 to over 500 million yuan in 2024, indicating strong market performance [10] Product Innovation - Meistick invests 44% of its profits annually in research and development, with a significant portion of its workforce dedicated to R&D, ensuring a robust technological moat [11][12] - The brand has developed a diverse product matrix covering 15 efficacy categories, including anti-aging and skin whitening, supported by a pharmaceutical-grade production facility [12][14] Market Strategy - The company employs a dual-channel strategy, integrating online and offline approaches to engage consumers effectively, while also participating in social responsibility initiatives [16] - Meistick's products have gained popularity among international celebrities and have been featured in top fashion magazines, enhancing its brand image [15][16]